Comparison of approaches for developing distributions for carcinogenic slope factors

Human and Ecological Risk Assessment (HERA)

Volumn 4, Issue 2, 1998, Pages 527-577

  Boyce, Catherine Petito ^a  

^a EXPONENT INC   (United States)

Author keywords

Decision analysis; Dose response modeling; PB PK modeling; Probabilistic risk assessment; Toxicity assessment

Indexed keywords

EID: 22044450782     PISSN: 10807039     EISSN: None     Source Type: Journal    
DOI: 10.1080/10807039891284415     Document Type: Article

References (50)

1. Allen, B.C., Covington, T.R., and Clewell, H.J. 1996. Investigation of the impact of pharmacokinetic variability and uncertainty on risks predicted with a pharmacokinetic model for chloroform. Toxicology 111, 289-303.
2. Bois, F.Y., Krowech, G., and Zeise, L. 1995. Modeling human in metabolism and risk: the example of 4-aminobiphenyl. Risk Anal. 15, 2, 205-213.
3. Bois, F.Y., Zeise, L., and Tozer, T.N. 1990. Precision and sensitivity of pharmacokinetic models for cancer risk assessment: tetrachloroethylene in mice, rats, and humans. Toxicol. Appl. Pharmacol. 102, 300-315.
4. Burmaster, D.E. and von Stackelberg, K. 1988. A new method for uncertainty and sensitivity analysis in public health risk assessments at hazardous waste sites using Monte Carlo techniques in a spreadsheet. In: Proceedings of the National Conference on Hazardous Waste and Hazardous Materials, pp. 550-556. Washington, DC, HMCRI, November 1988.
5. Clewell, H.J., III and Anderson, M.E. 1996. Use of physiologically based pharmacokinetic modeling to investigate individual versus population risk. Toxicology 111, 315-329.
6. Copeland, T.L., Paustenbach, D.J., Harris, M.A., and Otani, J. 1993. Comparing the results of a Monte Carlo analysis with EPA's reasonable maximum exposed individual (REMI): a case study of a former wood treatment site. Reg. Toxicol. Pharmacol. 18, 275-312.
7. Copeland, T.L., Holbrow, A.M., Otani, J.M., Connor, K.T., and Paustenbach, D.J. 1994. Use of probabilistic methods to understand the conservatism in California's approach to assessing health risks posed by air contaminants. J. Air Waste Manage. Assoc. 44, 1399-1413.
8. Cox., L.A., Jr. 1996. More accurate dose-response estimation using Monte-Carlo uncertainty analysis: The data cube approach. Hum. Ecol. Risk Assess. 2, 1, 150-174.
9. Cronin, W.J., IV, Oswald, E.J., Shelley, M.L., Fisher, J.W., and Flemming, C.D. 1995. A trichloroethylene risk assessment using a Monte Carlo analysis of parameter uncertainty in conjunction with physiologically-based pharmacokinetic modeling. Risk Anal. 15, 5, 555-565.
10. Crouch, E. 1990. Incorporating uncertainty into carcinogenic risk assessments for chemicals. Cambridge Environmental Inc., Cambridge, MA.
11. Crouch, E. 1992. MSTAGE Version 2.0. Cambridge Environmental, Inc., Cambridge, MA.
12. Crouch, E. 1993. How to derive uncertainty distributions for carcinogenic potency. Cambridge Environmental Inc., Cambridge, MA.
13. Crouch, EA.C. 1996a. Uncertainty distributions for cancer potency factors: Laboratory animal carcinogenicity bioassays and interspecies extrapolation. Hum. Ecol. Risk Assess. 2, 1, 103-129.
14. Crouch, E.A.C. 1996b. Uncertainty distributions for cancer potency factors: combining epidemiological studies with laboratory bioassays - the example of acrylonitrile. Hum. Ecol. Risk Assess. 2, 1, 130-149.
15. Crouch, E.A.C. and Green, L.C. 1993. Properly accounting for uncertainty in current methods of risk assessment. Poster presentation at Comparative Risk Analysis and Priority Setting for Air Pollution Issues, co-sponsored by the U.S. Environmental Protection Agency Environmental Criteria and Assessment Office; the Dutch Ministry of Housing Physical Planning and Environment; and the Air and Waste Management Association.
16. Crouch, E.A.C., R. Wilson, and L. Zeise. 1983. The risks of drinking water. Water Res. 19, 6, 1359-1375.
17. Cullen and Frey (in preparation). Developing distributions for use in probabilistic exposure assessment.
18. Dankovic, D.A., and Bailer, A.J. 1994. The impact of exercise and intersubject variability on dose estimates for dichloromethane derived from a physiologically based pharmacokinetic model. Fund. Appl. Toxicol. 22, 20-25.
19. Evans, J.S., Graham, J.D., Gray, G.M., and Sielken, R.L., Jr. 1994a. A distributional approach to characterizing low-dose cancer risk. Risk Anal. 14, 1, 25-34.
20. Evans, J.S., Gray, G.M., Sielken, R.L., Jr., Smith, A.E., Valdez-Flores, C., and Graham, J.D. 1994b. Use of probabilistic expert judgment in uncertainty analysis of carcinogenic potency. Regulat. Toxicol. Pharmacol. 20, 15-36.
21. Evers, T.K., Wilson, B., Kramel, R.C., and Travis, G.C. 1994. Quantitative analysis of uncertainty in cancer potency slope factors. Prepared for the U.S. Department of Energy.
22. Farrar, D., Allen, B., Crump, K., and Shipp, A. 1989. Evaluation of uncertainty in input parameters to pharmacokinetic models and the resulting uncertainty in output. Toxicol. Lett. 49, 371-385.
23. Gearhart, J.M., Mahle, D.A., Greene, R.J., Seckel, C.S., Flemming, C.D., Fisher, J.W., and Clewell, H.J., III. 1993. Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE). Toxicol. Lett. 68, 131-144.
24. Hasselblad, V. and Jarabek, A.M. 1996. Dose-response of toxic chemicals. In: Bayesian Biostatistics. pp. 235-259. (Berry, D.A., and Stangl, D.K., Eds.). New York, Marcel Dekker, Inc.
25. Helfand,J.S. and Mancy, K.H. 1993. Carcinogenesis risk assessment model for environmental chemicals. Water Sci. Tech. 27, 7-8, 279-286.
26. Kodell, R.L., Ahn, H , Chen, J.J., Springer, J.A., Barton, C.N., and Hertzberg, R.C. 1995. Upper bound risk estimates for mixtures of carcinogens. Toxicology 105, 199-208.
27. Li, H., Watanabe, K., Auslander, D., and Spear, R.C. 1994. Model parameter estimation and analysis: understanding parametric structure. Annals Biomed. Engineer. 22, 97-111.
28. McKone, T.E. and Bogen, K.T. 1991. Predicting the uncertainties in risk assessment. Environ. Sci. Technol. 25, 10, 1674-1681.
29. McKone, T.E. and Bogen, K.T. 1992. Uncertainties in health-risk assessment: an integrated case study based on tetrachloroethylene in California groundwater. Reg. Toxicol. Pharmacol. 15, 86-103.
30. Morgan, M.G. and Henrion, M.. 1990. Uncertainty: A Guide to Dealing with Uncertainty in Quantitative Risk and Policy Analysis. Cambridge University Press.
31. OSHA (Occupational Safety and Health Administration). 1992. Occupational Exposure to Formaldehyde. 29 CFR Part 1910.
32. Portier, C.J. and Kaplan, N.L. 1989. Variability of safe dose estimates when using complicated models of the carcinogenic process. Fund. Appl. Toxicol. 13, 533-544.
33. Sherman, C.D. and C.J. Portier. 1996. Stochastic simulation of a multistage model of carcinogenesis. Math. Biosci. 143, 35-50.
34. Sielken, R.L., Jr. and Stevenson, D.E. 1992. Comparisons of human cancer potency projections for dieldrin based on human data with those based on animal data. In: Relevance of Animal Studies to the Evaluation of Human Cancer Risk, pp. 295-319. Wiley-Liss, Inc.
35. Sielken, R.L., Jr., Bretzlaff, R.S., and Stevenson, D.E. 1994. Incorporating additional biological phenomena into two-stage cancer models. In: Receptor-Mediated Biological Processes: Implications for Evaluating Carcinogenesis, pp. 237-260. Wiley-Liss, Inc.
36. Smith, A.E. and Evans, J.S. 1995. Uncertainty in fitted estimates of apparent in vivo metabolic constants for chloroform. Fund. Appl. Toxicol. 25, 29-44.
37. Spear, R.C., and Bois, F.Y. 1994. Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results. Environ. Health Perspect. 102, Suppl. 11, 61-66.
38. Spear, R.C. Bois, F.Y., Woodruff, T., Auslander, D., Parker, J., and Selvin, S. 1991. Modeling benzene pharmacokinetics across three sets of animal data: parametric sensitivity and risk implication. Risk Anal. 11, 4, 641-654.
39. Thompson, K.M., Burmaster, D.E., and Crouch, E.A.C. 1992. Monte Carlo techniques for quantitative uncertainty analysis in public health risk assessments. Risk Anal. 12, 1, 53-63.
40. USEPA (U.S. Environmental Protection Agency). 1987a. Integrated Risk Information System Supportive Documentation, Volume I. Office of Research and Development, Office of Health and Environmental Assessment, Washington, DC. EPA/600/8-86/ 032a.
41. USEPA (U.S. Environmental Protection Agency). 1987b. The Risk Assessment Guidelines for 1986. Washington, DC. EPA/600/8-87/045.
42. USEPA (U.S. Environmental Protection Agency). 1992. Internal memorandum dated February 26, 1992, from F.H. Habicht II, Deputy Administrator to Assistant and Regional Administrators, regarding guidance on risk characterization for risk managers and risk characterization for risk managers and risk assessors. Washington, DC.
43. USEPA (U.S. Environmental Protection Agency). 1995a. Internal memorandum dated March 21, 1995, from C.M. Browner, EPA Administrator, regarding EPA risk characterization program. Washington, DC.
44. USEPA (U.S. Environmental Protection Agency). 1995b. Exposure factors handbook. Office of Research and Development, Washington, DC. EPA/600/P-95/002A.
45. USEPA (U.S. Environmental Protection Agency). 1996. Proposed guidelines for carcinogenic risk assessment. Fed. Reg. 61, 79, 17960.
46. USEPA (U.S. Environmental Protection Agency). 1997. Exposurefactors handbook. Office of Research and Development, Washington, DC. EPA/600/P-95/002Fa-c.
47. USEPA (U.S. Environmental Protection Agency). 1997b. Integrated Risk Information System (IRIS) files for benzene and benzo[a]pyrene. Current as of September 1997. Office of Health and Environmental Assessment, Cincinnati, OH.
48. Watanabc, K.H. and Bois, F.Y. 1996. Interspecies extrapolation of physiological pharmacokinetic parameter distributions. Risk Anal. 16(6), 741-754.
49. Woodruff, T.J. and Bois, F.Y. 1993. Optimization issues in physiological toxicokinetic modeling: a case study with benzene. Toxicol. Lett. 69, 181-196.
50. Woodruff, T.J., Bois, F.Y., Auslander, D., and Spear, R.C. 1992. Structure and parameterization of pharmacokinetic models: their impact on model predictions. Risk Anal. 12, 2, 189-201.